STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Tevogen Bio Holdings Inc.

Filed

March 17, 2026

Period of Report

March 10, 2026

Accession Number

0001123292-26-000465